International Circulation

How should we deal with cardiotoxicity caused by immunotherapy?

TCT2021 | Ten-year All-cause Death After Percutaneous or Surgical Revascularization in Diabetic Patients With Complex Coronary Artery Disease

AHA 2021 | Looking forward to the future of interventional therapy of valvular heart disease

TCT2021 | There is no difference in the 5-year results of the SURTAVI of TAVR or SAVR among intermediate-risk patients

Can the cost-benefit advantage of TAVR in patients with low surgical risk be long-lasting?

For bifurcation lesions,the duration of DAPT is not as short as possible

How to choose a treatment strategy for patients with CABG contraindications?

An Overview of congenital heart disease prevention and treatment

How to choose antithrombotic therapy for patients with high bleeding risk